Littoinen, Finland

Liisa Huovinen

This inventor holds 1 USPTO granted patent. Top assignee: Oy Juvantia Pharma Ltd.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liisa Huovinen. Retrieved from https://idiyas.com/inventor/liisa-huovinen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Liisa Huovinen: Innovator in Medical Treatments

Introduction

Liisa Huovinen is a notable inventor based in Littoinen, Finland. She has made significant contributions to the field of medical treatments, particularly through her innovative approaches to disease prevention and treatment.

Latest Patents

Liisa Huovinen holds a patent for a method aimed at the treatment or prevention of diseases mediated by the alpha-2B-adrenoceptor. This method involves administering an effective amount of a selective alpha-2B-adrenoceptor antagonist to a mammal. The antagonist is chosen from a group of compounds disclosed in her patent, which includes compounds A, B, C, D, and E, or their pharmaceutically acceptable salts. This patent highlights her commitment to advancing medical science and improving health outcomes.

Career Highlights

Liisa is associated with Oy Juvantia Pharma Ltd., where she continues to work on innovative solutions in the pharmaceutical industry. Her expertise and dedication have positioned her as a valuable asset in her field.

Collaborations

Throughout her career, Liisa has collaborated with esteemed colleagues, including Siegfried Wurster and Mia Engström. These partnerships have fostered a collaborative environment that enhances the development of new medical treatments.

Conclusion

Liisa Huovinen's contributions to medical innovation through her patent and work at Oy Juvantia Pharma Ltd. underscore her role as a leading inventor in her field. Her dedication to improving health through innovative methods is commendable and impactful.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…